Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2275 of 3270 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 11/18/20
End: 11/18/23
Due: 11/18/24
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 03/04/20
End: 03/04/25
Due: 03/04/26
Phase: N/A
Priority: Normal
Start: 09/27/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 04/30/20
Due: 04/30/21
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 09/13/18
Due: 09/13/19
Phase: N/A
Priority: Normal
Start: 08/27/24
End: 01/01/25
Due: 01/01/26
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 12/31/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 09/30/17
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 05/23/19
Due: 05/23/20
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 04/30/06
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 12/31/18
Due: 12/31/19
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
Phase: N/A
Priority: Normal
Start: 09/08/23
End: 09/08/27
Due: 09/08/28
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 09/29/22
End: 06/02/23
Due: 06/02/24
Phase: N/A
Priority: Normal
Start: 04/21/21
End: 10/01/27
Due: 10/01/28